© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
759368 |
As an accredited 2-Amino-5-Bromo-3-Fluorobenzoic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Amino-5-Bromo-3-Fluorobenzoic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ask anyone who has worked in advanced organic chemistry or pharmaceutical research, and they’ll tell you how the search for effective intermediates shapes every project’s pace and direction. 2-Amino-5-Bromo-3-Fluorobenzoic Acid—let’s call it ABFBA for short—stands out for its purposeful design. This isn’t just another benzoic acid derivative. For those who care about clear differentiation, ABFBA brings together a unique mix of halogens and an amino group, each positioned to offer chemists a versatile starting point for more specialized molecules.
Breaking down its real-world impact starts with the compound’s details: ABFBA features a bromine atom at the five-position and a fluorine atom at the three-position on the benzene ring, plus an amino group at position two. Structurally, this arrangement does more than check boxes on a molecular diagram—it provides defined handles for further modification. A solid with measurable weight (likely between 245 and 250 g/mol by formula), ABFBA arrives in pure crystalline form for most reputable suppliers. Labs consistently find it offers good chemical stability, remaining manageable during standard storage—it doesn’t demand refrigeration or exotic containers, unlike more volatile or sensitive compounds.
What matters most for those at the bench is reliability in reactions. Researchers often hunt for compounds that play well during substitutions, amidations, and couplings. ABFBA’s layout, blending one electron-donating and two electron-withdrawing groups, encourages selective transformations. That selective reactivity can mean less wasted time troubleshooting unpredictable reactions. And anyone who’s sat through hours of failed syntheses knows how valuable that is.
Most ABFBA shipped out doesn’t remain in storage cabinets—it works as a reliable intermediate in medicinal chemistry programs. Chemists appreciate the distinct halogen pattern because the mix of bromine and fluorine influences electronic characteristics and biological interactions. Pharmaceutical development programs, in particular, lean on these features. Fluorine modification of drug molecules can dramatically change their absorption, metabolic stability, or even safety profile. Bromine, less commonly found in nature, offers a useful moiety for further elaboration, such as through palladium-catalyzed cross-coupling reactions.
Over the past decade, a growing number of research reports and patents mention combinations of halogenated and aminated aromatics just like ABFBA as key fragments for kinase inhibitors, anti-inflammatories, or CNS-targeted agents. Medicinal chemists often start with ABFBA because its building blocks support rapid structure-activity relationship exploration. By tweaking the amine or halogen positions—or swapping out the acid function—teams can quickly scan for target binding or cut down on side effects. In a job where every week counts, the flexibility and predictability ABFBA brings make it a foundational material for innovating new drug candidates.
Chemical catalogs brim with hundreds of benzoic acid analogs, but few blend a bromo with a fluoro substitution adjacent to an amine. Many related compounds lack the electronic diversity of ABFBA. Some might offer just one halogen, or place the amine further from the site of desired reaction. These differences shift electronic density and influence both reactivity and biological compatibility.
My own experiences in the lab drove this home. I’ve seen benzoic acid analogs with chlorine, iodine, or methyl groups frustrate researchers when they stumble on an unwanted side product or get poor conversion in a coupling reaction. Swapping in a fluorine at the three-position, as in ABFBA, improves the electrophilicity at adjacent positions while still keeping the molecule manageable under classic synthetic conditions. The bromine’s size and reactivity offer a reliable “hook” for cross-coupling, which broadens the pathway for generating complex molecules downstream.
Another distinction comes in accessibility. Many benzoic acid derivatives require custom synthesis or arrive with purity challenges. Credible ABFBA sources routinely supply this compound with purity levels over 98 percent, reducing the need for time-consuming re-purification. For academic labs and industry-scale partners, this reliability avoids workflow delays that come from patchy supply or inconsistent material.
A colleague once recounted her team’s struggle with a program targeting new anti-epileptic therapies. Their lead molecules needed both fluorine to increase central nervous system penetration and an amine group to interact with the target enzyme. Starting with ABFBA, she bypassed several synthetic hurdles her group had faced using less functionalized benzoic acids. The compound’s halogen pattern meant cleaner reaction profiles, easier purification, and a chemical “platform” that could endure the multi-step journey from the bench to a pilot batch.
In agrochemical development, another research group described using ABFBA as the launching pad for herbicide analogs. The combination of halogens on the ring shifted soil permeability and plant uptake compared to traditional single-halogen benzoic acids. The result was new options for crop protection compounds that met regulatory hurdles for residue and safety.
Regular benzoic acid derivatives, lacking such precise halogenation, offered fewer sites for quick functionalization or required risky, moisture-sensitive steps to fill in the missing pieces. Time lost troubleshooting low-yielding or impure products can crush a development timeline, especially with funding or patent milestones looming. Teams using ABFBA skipped weeks of custom synthesis and characterization, jumping straight to optimization of biological properties.
Publications in journals such as Journal of Medicinal Chemistry routinely highlight the importance of trifunctionalized benzoic acids. Reviews examine how specific combinations—like the one ABFBA offers—lead to improvements in metabolic stability, binding selectivity, or synthesis scalability. In patent filings, the use of ABFBA streamlines lead optimization, opening the door to families of molecules that might otherwise remain out of reach due to synthetic complexity. These claims often include data from structure-activity relationship studies, animal models, or early-stage clinical predictions.
In medicinal chemistry, every atom can shift a drug candidate’s fate in preclinical assays. A fluorine atom can extend half-life or dodge metabolic breakdown. A bromine not only changes electronic properties but also offers a reliable exit for creating carbon-carbon or carbon-heteroatom bonds. Combining those functions on a single aromatic core isn’t trivial, which is why ABFBA holds up under scientific scrutiny.
Any chemist balancing real-world constraints, like lab throughput or environmental compliance, knows the benefits of a robust intermediate. ABFBA ships well, handles easily under standard lab techniques, and offers solid shelf-life without special permissions or handling requirements for most research uses. Documented analytical fingerprints, including melting point and spectral characteristics, mean labs can confirm its identity with straightforward tests—NMR or HPLC—without specialized protocols.
Clean reactivity also means fewer impurities or byproducts. For scale-up, the ability to sidestep tricky crystallization or chromatography steps can make or break project costs. In my view, that reliability deserves more attention: a well-behaved intermediate frees up resources for creative synthesis instead of troubleshooting.
Researchers today face mounting pressure to avoid hazardous or environmentally harmful materials. ABFBA’s structural features increase research productivity but also support better stewardship. Its bromine and fluorine content mean it’s not completely benign, but compared to more volatile or toxic aromatic compounds, ABFBA offers a reasonable profile when handled with basic precautions. Waste management and emissions controls for halogenated aromatics remain key considerations, and many universities and companies have published guidelines for safe use and disposal.
The move toward responsible chemistry encourages scientists not just to optimize their end products but to select intermediates that avoid unnecessary hazards from the start. ABFBA fits into that conversation. Labs—especially those training students—benefit from intermediates that don’t require elaborate protective set-ups, while still yielding high-quality results.
The right intermediate removes guesswork and starts every synthesis on solid footing. By using ABFBA, companies have cut down on rework and troubleshooting during scale-up. In pharmaceutical contract research, for example, switching to ABFBA as a starting point for kinase inhibitor syntheses sliced weeks off total development timelines. Startups and academic spin-outs, often running with lean teams and shoestring budgets, value the assurance that comes from predictable chemistry.
It’s tempting to dismiss incremental improvements in intermediate selection as details, but project managers and bench scientists know better. Inefficient intermediates balloon project costs, delay regulatory filings, and sometimes scuttle promising lead molecules entirely. ABFBA delivers both practical and strategic value by streamlining synthesis and confirming results with standard analytical techniques.
Younger researchers or teams branching into more complex aromatic synthesis can learn a lot from compounds like ABFBA. The straightforward handling regime and clear reactivity provide early wins, which builds confidence. Learning to predict and control selectivity—honed by working with ABFBA’s unique group arrangement—translates directly to bigger projects down the line.
I recall a series of student projects where ABFBA’s predictability reduced stress. Instead of running several reactions in parallel “just in case,” students ran one, monitored its progress cleanly, and moved on to the next step without backtracking. Less waste, less confusion, and more satisfying results—those small victories help retain budding chemists in an industry that’s always on the hunt for sharp minds.
Supply chain disruptions over recent years have forced chemists to reconsider their starting materials. ABFBA’s widespread adoption by reputable producers, strong demand in pharmaceutical and agrochemical sectors, and reliable quality controls mean it now enjoys a stable foothold. Labs tired of back orders or batch-to-batch quality swings in more exotic intermediates have moved toward ABFBA. A good supply of a workhorse intermediate lets teams adapt quickly to changing research priorities or seize new commercial opportunities.
Looking forward, as synthetic methods advance and research on halogenated benzoic acids expands, ABFBA’s role is likely to increase. Ongoing work in C–H activation, site-selective halogenations, and green chemistry has started to unlock yet more applications for molecules built from platforms like ABFBA. The drive toward greener, more sustainable synthesis strengthens the case for using intermediates that minimize the need for harsh conditions or toxic reagents—and ABFBA fits nicely with many of the latest methodologies.
No intermediate solves every problem. In environments with strict halogen waste restrictions, labs look for viable alternatives that maintain reactivity without raising regulatory flags. Although ABFBA contains both bromine and fluorine, recent advances in recovery and recycling of halogenated byproducts have softened these hurdles. More manufacturers are offering ABFBA versions certified to high environmental and trace impurity standards, supporting responsible use while maintaining chemical integrity.
Where access or pricing once limited adoption, increased demand has prompted suppliers to offer more competitive pricing for research and pilot-scale orders. Academic purchasing consortia and industry-university partnerships have helped by sharing best procurement practices and forecasting demand. These initiatives allow even smaller labs to access ABFBA without the bottlenecks often seen with less common advanced intermediates.
For the future, integrating better digital inventory tracking and closer collaboration across supply networks could further ease access. Improved forecasting of bulk needs, coupled with agile synthesis routes developed in academic settings, would help smooth out spikes in demand. Cross-disciplinary efforts among chemists, logistic specialists, and regulatory experts could encourage responsible sourcing, better waste minimization, and broader educational outreach about the value of intermediates like ABFBA.
The next generation of pharmaceuticals, crop protectants, dyes, and sensors will depend on stable, reliable intermediates that let chemists focus on innovation instead of trouble-shooting. My own time in applied synthesis has convinced me that intelligent use of robust intermediates like ABFBA makes a world of difference, not just in individual reactions but in the culture of a research team. Less time spent fighting problematic chemistry frees up bandwidth for thinking bigger, exploring new reaction space, or mentoring the next batch of scientists.
The flexibility and assurance ABFBA offers extend through to patent protection, easier regulatory documentation, and—crucially—faster movement from discovery to real-world application. By building pipelines around well-understood, accessible starting points, labs gain agility against shifting trends, regulatory demands, or even abrupt funding cuts. In challenging times, that resilience could spell the difference between getting stuck and making a breakthrough.
A compound like 2-Amino-5-Bromo-3-Fluorobenzoic Acid highlights that effective discovery rests not on luck, but the sum of smart choices about materials, workflow, and stewardship. Scientists, educators, project managers, and producers each bring a unique perspective. Open communication about challenges and solutions at each stage—from raw material handling to late-stage process development—ensures that ABFBA isn’t just a name in a database, but a living part of a larger effort to streamline chemistry for the better.
No compound guarantees success in every project, and ABFBA’s suitability always depends on the specifics of each research challenge. Yet, in my experience and through countless conversations with colleagues, the choice of reliable, versatile intermediates does more than improve yields—it empowers scientists to take creative leaps, respond to setbacks with resilience, and elevate the standards by which the entire industry operates. ABFBA, with its decade-long record of service in labs both large and small, stands as a quiet enabler of innovation, time and again.
